E-cigarette, or Vaping, product use-Associated Lung Injury (EVALI): a diagnosis of exclusion
EVALI (e-cigarette or vaping product use-associated lung injury) is a relatively new disease with complex differential diagnosis, as it mimics the clinical and pathological picture of various pulmonary diseases. The diversity of clinical manifestations of the disease described in the literature necessitates for treating EVALI as a diagnosis of exclusion and requires accumulation and understanding of the data to develop effective methods for diagnosis and patient management. The aim of the work was to present a clinical observation of vaping-associated lung injury (EVALI) in an adolescent as a diagnosis of exclusion. Conclusion. The presented clinical case demonstrates vaping-associated lung injury in a 15-year-old girl and the importance of high-quality collection of medical history for timely and correct diagnosis.
Authors
- S. A. Tsarkova (ORCID: https://orcid.org/0000-0003-4588-5909)
- И. В. Лещенко (ORCID: https://orcid.org/0000-0002-1620-7159)
- А. I. Ivanova (ORCID: https://orcid.org/0009-0007-4444-8033)
- Zhanna A. Tsareva
- Valentina R. Lipina
Institutions
- Ural State Medical University (RU)
- Ural research Institute of Phthisiopulmonology (RU)
- Autonomous Healthcare (US)
- Children's City Clinical Hospital №11 (RU)
Publication Details
- Journal
- PULMONOLOGIYA
- Published
- 2024-12-26
- DOI
- https://doi.org/10.18093/0869-0189-2024-4604
- Citations
- 1
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.33